With hypertension affecting 1.3 billion people worldwide, experts stress that poor diagnosis and treatment adherence continue ...

Two pivotal trials of the aldosterone synthase inhibitor have shown positive results for lorundrostat in uncontrolled and ...

Hypertension (high blood pressure) increases the risk of cardiovascular disease and mortality. Learn how damage from ...

A recent health survey in Kathmandu has uncovered troubling numbers that reveal a growing health crisis among the city ...

High blood pressure strikes Black Americans earlier and more severely than other groups. Discover 6 strategies and ...

Optimizing copper, manganese, and vitamin B12 during pregnancy can help lower the risk for high blood pressure and hy ...

Short sleep duration, with and without self-reported insomnia, was predictive of elevated blood pressure and hypertension ...

Historical data show the prevalence of pulmonary arterial hypertension (PAH) in adult patients with congenital heart disease ...

Renal denervation offers a potentially transformative and minimally invasive option for treating hypertension. With this ...

A study suggests that B vitamins could be an effective way to lower blood pressure, especially for people who do not respond ...

Topline data were announced from a phase 3 trial investigating lorundrostat for the treatment of uncontrolled hypertension or resistant hypertension.

Mineralys’ shares got a more than 50% boost Monday morning as new data showed its hypertension drug reduced blood pressure in ...